Day: January 25, 2022

VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI) (“Titan” or the “Company”) is pleased to release preliminary fourth quarter (“Q4”) and full year 2021 production results and provide 2022 operating, capital and exploration expenditure guidance (all dollar figures are in US dollars, unless otherwise indicated). 2021 HighlightsImproved safety performance, decreasing incident severity rate 95%. Produced 47.5 million payable pounds of zinc in 2021, a record since re-opening of the Empire State Mine. Implemented a fixed price arrangement hedging program covering 50% of H2/21 payable production and 60%, or 8.4 million pounds, of forecasted Q1/22 payable production. Declared an inaugural special cash dividend of C$0.01 per share at the end of Q3 (paid in October 2021) and declared a second...

PLAINVIEW, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its fourth quarter and full year 2021 financial results after the market closes on Wednesday, February 16, 2022. The company will host a conference call to review these results starting at 5:00pm ET that day. To join the call, dial 1-888-220-8451 (toll free) or 1-646-828-8193 and use passcode 9212833. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET that same evening. About Veeco Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch...

The Orchards Features Brand-New Homes Starting from the $380s Near Yuba CityThe Stinson plan is a stunning two-story home available now at The Orchards by LGI Homes.The Stinson plan is a gorgeous, two-story home that features five bedrooms, a spacious layout, chef-ready kitchen and a host of designer upgrades included.LINDA, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of a brand-new section of homes at their popular community, The Orchards, located near Yuba City, California. Within this family-friendly community, LGI Homes offers five spacious floor plans ranging in size from 1,292 square feet to just over 2,200 square feet. These floor plans consist of one- and two-story, single-family homes with up to five bedrooms and three full baths. Every home within...

NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Rivalry Corp. (TSX-V: RVLY; OTCQX: RVLCF), a sports betting and media company, has qualified to trade on the OTCQX® Best Market. Rivalry Corp. upgraded to OTCQX from the Pink® market. Rivalry Corp. begins trading today on OTCQX under the symbol “RVLCF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information...

Lantronix Showcases IoT, Lighting and Connectivity Solutions for Smart Cities, Intelligent Buildings, Federal and Local Government and Data Centers IRVINE, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Intelligent IT and the Internet of Things (IoT), today announced it will exhibit at the BICSI Winter 2022 Conference & Exhibition. Taking place Jan. 30–Feb. 3, 2022, the event is being held at the Orlando World Center Marriott Resort & Convention Center. Lantronix will exhibit at booth 1033. “At BICSI, Lantronix will showcase innovative solutions for Smart Cities and intelligent buildings, including PoE lighting and ITS solutions as well as products for Federal and local government and data centers,” said Jacques Issa, VP of Marketing at Lantronix....

NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Callinex Mines Inc. (TSX-V: CNX; OTCQX: CLLXF), a mineral exploration company advancing a portfolio of copper and zinc rich mineral deposits located in Canada, has qualified to trade on the OTCQX® Best Market. Callinex Mines Inc. upgraded to OTCQX from the Pink® market. Callinex Mines Inc. begins trading today on OTCQX under the symbol “CLLXF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined...

33.8m at 88 g/t Ag VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to report the initial results from the Phase III diamond drilling program at the Virginia Silver Project (“Virginia”) in the province of Santa Cruz, Argentina. Virginia is operated by the Company and funded by Silver Sands Resources Corp. (CSE: SAND; OTCPK: SSRSF) under an option-to-purchase agreement (see News Release May 21, 2020). If the option is exercised, Mirasol will retain a 19.9% equity ownership in Silver Sands and a 3% NSR royalty (with a buydown to 2% for US$2M). Continued drilling at Ely Central returned a broad interval of 33.8m at 88 g/t silver (“Ag”) from 71.3m in hole EC-DDH-008, which successfully closes the gap between the mineralized structured...

Expanding patient base and potential of Imara’s small molecule oral inhibitor of phosphodiesterase-9 (PDE9) alongside hemoglobin disorders Phase 2 trial aims to select HFpEF patients with enriched PDE9 expressionfor targeted approach to a heterogeneous disease Study initiation planned for second quarter of 2022 BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) —  Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare hemoglobin disorders and other serious diseases, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND) application for tovinontrine (IMR-687) to commence clinical development for the treatment of heart failure with preserved ejection fraction (HFpEF). Imara...

Company AnnouncementNet sales of DARZALEX® in 2021 totaled USD 6,023 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc.Copenhagen, Denmark; January 25, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) formulation (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by Johnson & Johnson were USD 6,023 million in 2021. Net trade sales were USD 3,169 million in the U.S. and USD 2,854 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC formulations, under the exclusive worldwide license to Janssen Biotech, Inc. (Janssen) to develop, manufacture and commercialize daratumumab....